DTIL
PRECISION BIOSCIENCES INC
NASDAQ · Healthcare · Biotechnology · US
$6.19
+7.28%3
Insider buys (3m)
0
Insider sells (3m)
$29.5K
Net value (3m)
-17.8%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 30, 2026 | Frankel Stanley · director | Purchase | 1,000 | $6.00 |
| Sep 29, 2026 | Brown Melinda · director | Purchase | 1,135 | $6.27 |
| Sep 29, 2026 | Germano Geno J · director | Purchase | 2,609 | $6.28 |
| Jun 5, 2026 | Frankel Stanley · director | A-Award | 20,979 | $0.00 |
| Jun 5, 2026 | Brown Melinda · director | A-Award | 20,979 | $0.00 |
| Jun 5, 2026 | Buehler Kevin · director | A-Award | 20,979 | $0.00 |
| Jun 5, 2026 | Pire Shari Lisa · director | A-Award | 20,979 | $0.00 |
| Jun 5, 2026 | Germano Geno J · director | A-Award | 20,979 | $0.00 |
| May 22, 2026 | Frankel Stanley · director | M-Exempt | 21,000 | $0.00 |
| May 22, 2026 | Buehler Kevin · director | M-Exempt | 21,000 | $0.00 |
| May 22, 2026 | Brown Melinda · director | M-Exempt | 21,000 | $0.00 |
| May 22, 2026 | Pire Shari Lisa · director | M-Exempt | 21,000 | $0.00 |
| May 22, 2026 | Germano Geno J · director | M-Exempt | 21,000 | $0.00 |
| Feb 19, 2026 | Kelly John Alexander · officer: Chief Financial Officer | M-Exempt | 27,584 | $0.00 |
| Feb 19, 2026 | Scimeca Dario · officer: General Counsel and Secretary | M-Exempt | 16,667 | $0.00 |
| Feb 19, 2026 | Scimeca Dario · officer: General Counsel and Secretary | Sale | 4,925 | $3.84 |
| Feb 19, 2026 | Amoroso Michael · director, officer: President and CEO | Sale | 20,559 | $3.84 |
| Feb 19, 2026 | Amoroso Michael · director, officer: President and CEO | M-Exempt | 67,797 | $0.00 |
| Feb 19, 2026 | SMITH J. JEFFERSON · officer: Chief Research Officer | Sale | 4,925 | $3.84 |
| Feb 19, 2026 | SMITH J. JEFFERSON · officer: Chief Research Officer | M-Exempt | 16,667 | $0.00 |
| Feb 19, 2026 | Kelly John Alexander · officer: Chief Financial Officer | Sale | 8,149 | $3.84 |
| Jan 22, 2026 | Kelly John Alexander · officer: Chief Financial Officer | M-Exempt | 13,900 | $0.00 |
| Jan 22, 2026 | Amoroso Michael · director, officer: President and CEO | M-Exempt | 69,421 | $0.00 |
| Jan 22, 2026 | Amoroso Michael · director, officer: President and CEO | Sale | 34,799 | $4.17 |
| Jan 22, 2026 | Amoroso Michael · director, officer: President and CEO | M-Exempt | 37,069 | $0.00 |
| Jan 22, 2026 | Amoroso Michael · director, officer: President and CEO | M-Exempt | 8,888 | $0.00 |
| Jan 22, 2026 | Scimeca Dario · officer: General Counsel and Secretary | M-Exempt | 14,908 | $0.00 |
| Jan 22, 2026 | Scimeca Dario · officer: General Counsel and Secretary | Sale | 8,854 | $4.03 |
| Jan 22, 2026 | Scimeca Dario · officer: General Counsel and Secretary | M-Exempt | 8,425 | $0.00 |
| Jan 22, 2026 | Scimeca Dario · officer: General Counsel and Secretary | M-Exempt | 1,978 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 51Increased 55Reduced 29Sold out 18
| Filer | Action | Shares | Filed |
|---|---|---|---|
| OCTAGON CAPITAL ADVISORS LP | Increased | 2,236,732 | May 15, 2026 |
| Aberdeen Group plc | Unchanged | 2,230,178 | Jul 31, 2026 |
| ABRDN PLC | Increased | 2,230,178 | Apr 29, 2026 |
| Bleichroeder LP | Increased | 2,018,190 | Aug 13, 2026 |
| EMPERY ASSET MANAGEMENT, LP | Reduced | 1,968,879 | May 8, 2026 |
| BLEICHROEDER LP | Unchanged | 1,662,500 | May 14, 2026 |
| Octagon Capital Advisors LP | Reduced | 1,350,000 | Aug 14, 2026 |
| BOOTHBAY FUND MANAGEMENT, LLC | Increased | 1,346,004 | Aug 14, 2026 |
| BlackRock, Inc. | Increased | 1,172,873 | Aug 7, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 1,116,241 | Aug 13, 2026 |
| BOOTHBAY FUND MANAGEMENT, LLC | Unchanged | 1,066,050 | May 15, 2026 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | Increased | 995,371 | May 15, 2026 |
| LYNX1 CAPITAL MANAGEMENT LP | Reduced | 985,113 | May 4, 2026 |
| Lynx1 Capital Management LP | Reduced | 950,466 | Aug 13, 2026 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | Reduced | 946,707 | Aug 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 30, 2026